Prama Ghosh, Amity University Kolkata
The Food and Drug Administration announced granted emergency use authorization to Moderna’s mRNA–1273, it’s COVID-19 vaccine for use in individuals 18 and older Friday night, the second vaccination against the coronavirus in the United States one week after the agency authorized a similar vaccine from Pfizer and BioNTech.
Moderna’s vaccine is more than 94% effective just like Pfizer’s vaccine which is already in use. mRNA–1273 can be stored and transported at a temperature maintained by a standard refrigerator for 30 days. It requires two doses given 28 days apart, unlike 21 days for the Pfizer shot. The mRNA technology used by both Moderna and Pfizer vaccines provides a recipe to the body. To make the spike proteins found on the outside of the coronavirus, which triggers an immune response.
Under Operation Warp Speed two-hundred million doses of Moderna’s vaccine have already been ordered by the US government. The government also has an option to purchase up to 300 million additional doses. Post authorization of both Pfizer and Moderna’s vaccines, around 20 million people are expected to be vaccinated by the end of the year. FDA Commissioner Stephen M. Hahn, M.D. has taken another crucial step. Making two vaccines available for the prevention of COVID-19. On average 216,000 new cases are being recorded in the U.S per day with deaths reaching as high as 3,600 per day. Moderna plans its future trials which include continued studies in children with a closer look at possible serious reactions, including Bell’s palsy.
Also read: Triple-negative breast cancer and PARP inhibitor to overcome immunosuppressive macrophages
References:
2) https://spectrumnews1.com/ky/northern-ky/news/2020/12/19/moderna-covid-vaccine-fda-emergency-use
- The Corrosion Prediction from the Corrosion Product Performance
- Nitrogen Resilience in Waterlogged Soybean plants
- Cell Senescence in Type II Diabetes: Therapeutic Potential
- Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
- AI Literacy in Early Childhood Education: Challenges and Opportunities
2 thoughts on “Moderna’s mRNA–1273 granted emergency use authorization by FDA”